Drug Discovery World

SEPTEMBER 26, 2022

DDW Editor Reece Armstrong explores the rise of drug repurposing and the benefits and disadvantages it brings to drug discovery and development. . It’s common knowledge that drug discovery and development is costly, lengthy and has no guarantee of success. Benefits and barriers . However, challenges remain.

Drugs 52

Drugs Genome Genomics Clinical Trials 52

The Pharma Data

AUGUST 21, 2020

Fortunately, as a member of the Novartis Business Development & Licensing (BD&L) department, she was in a position to try to help. She joined the Novartis COVID-19 R&D Task Force to help tackle the emerging pandemic, taking the reins of the business development workstream. First, do we believe in the goals?

Business Development 52

Business Development Licensing Licensing Development 52

XTalks

OCTOBER 1, 2020

And although academia and industry have often been pitted against each other in the realm of scientific discovery and development, there may be more similarities and synergies between the two than we may think. WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation.

Scientist 52

Scientist In-Vitro Research Life Science 52